CRT 2025 BEST INNOVATIONS COMPETITION

Monday, March 10, 2025

2:40 PM – 5:30 PM ET

Chair(s)

Steven R. Bailey, MD, MSCAI

Professor of Medicine
LSU Health Shreveport
San Antonio, Texas, United States

Disclosure information not submitted.

Co-Chair(s)

Israel Barbash, MD

Interventional Cardiologist
Leviev Heart Center, Sheba Medical Center
Shoham, HaMerkaz, Israel

Disclosure(s): No financial relationships to disclose

Judge(s)

Yuval Binur, PhD

Managing Partner
Arsuf Global Partners
NEW YORK, New York, United States

Disclosure information not submitted.
Sam Chitsaz, MD FACC FSCAI

Interventional Cardiologist
Sutter Health

Disclosure(s): No financial relationships to disclose
Tim A. Fischell, MD, FACC

Director of Cardiovascular Research
Ascension Borgess Heart Institute
Kalamazoo, Michigan, United States

Disclosure(s): Ablative Solutions, Inc.: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Salary (Ongoing), Stock-privately held company (Ongoing); Cordis, Endovascular Division: Royalties (Ongoing); Vantis Vascular, Inc.: Employee (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Salary (Ongoing), Stock-privately held company (Ongoing)
Nicolas Foin, MSc, PhD

Founder/ Adj Associate Professor
Dhenin/ Duke-NUS Medical School
Brussels, Brussels Hoofdstedelijk Gewest, Belgium

Disclosure(s): CoreAalst: Consulting Fees (e.g., advisory boards) (Ongoing), Executive Board (Ongoing); Medinbox: Consultant (Ongoing), Exec. Board, Mandate (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
Chaim Shaul Lotan, MD

Chief Innovation Officer
Hadassah-Hebrew University Medical Center
Jerusalem, Israel

Disclosure(s): No financial relationships to disclose
Jonathan Schwartz, MD

Structural Interventional Cardiologist
Sanger Heart & Vascular Institute, North Carolina, United States

Disclosure(s): Abbott Vascular: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Boston Scientific: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Cordis: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); CorFlow Therapeutics: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Edwards Lifesciences: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Lifelens LLC: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Medtronic: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Philips: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); RapidAI: Consultant (Ongoing); Siemens: Consultant (Ongoing); W.L. Gore & Associates: Consultant (Ongoing)
Valavanur A. Subramanian, MD

Founder and Director Of Board
HRT- Heart Repair Technologies Inc.
New York, New York, United States

Disclosure(s): No financial relationships to disclose
Mark A. Turco, MD

CEO & President
JC Medical and Genesis MedTech
Providence, Rhode Island, United States

Disclosure information not submitted.
Alan Yeung, MD, FSCAI

Chief, Cardiovascular Medicine
Stanford University
Stanford, CA, United States

Disclosure information not submitted.

Disclosure(s):

Israel Barbash, MD: No financial relationships to disclose

Sam Chitsaz, MD FACC FSCAI: No financial relationships to disclose

Tim A. Fischell, MD, FACC: Ablative Solutions, Inc.: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Salary (Ongoing), Stock-privately held company (Ongoing); Cordis, Endovascular Division: Royalties (Ongoing); Vantis Vascular, Inc.: Employee (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Salary (Ongoing), Stock-privately held company (Ongoing)

Nicolas Foin, MSc, PhD: CoreAalst: Consulting Fees (e.g., advisory boards) (Ongoing), Executive Board (Ongoing); Medinbox: Consultant (Ongoing), Exec. Board, Mandate (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Chaim Shaul Lotan, MD: No financial relationships to disclose

Jonathan Schwartz, MD: Abbott Vascular: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Boston Scientific: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Cordis: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); CorFlow Therapeutics: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Edwards Lifesciences: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Lifelens LLC: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Medtronic: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Philips: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); RapidAI: Consultant (Ongoing); Siemens: Consultant (Ongoing); W.L. Gore & Associates: Consultant (Ongoing)

Valavanur A. Subramanian, MD: No financial relationships to disclose